跳至主要内容
临床试验/RBR-2v2mwkz
RBR-2v2mwkz已完成3 期

Pharmacokinetics and placental transfer studies of betamethasone in twin pregnancies

Faculdade de Medicina de Ribeirão Preto0 个研究点开始时间: 2021年2月10日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18Y 至 0(—)
性别
Female

入选标准

  • Adult women (> 18 years) with single or multiple pregnancies of morphologically normal fetuses, with gestational age between 24 - 34 weeks; risk of imminent prematurity and therefore, with an indication of antenatal administration of betamethasone to stimulate fetal maturity; normal biochemical and hematological parameters.

排除标准

  • Smoking, alcoholism, and/or use of illegal substances; maternal diseases that develop vasculopathy and influence uteroplacental flow, such as hypertension, uncontrolled diabetes, heart disease, kidney disease, or thrombophilia; fetuses with congenital anomaly; injury identification in target organs by laboratory examination.

研究者

发起方
Faculdade de Medicina de Ribeirão Preto

相似试验

The influence of twin pregnancy on the kinetic... | 临床试验